What is Semaglutide?
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist with a long half-life. It is among the most-studied metabolic research peptides because of the extensive GLP-1 literature on glucose handling and satiety signaling.
How Semaglutide works (research mechanism)
Semaglutide research centers on GLP-1-receptor activation: enhanced glucose-dependent insulin signaling, slowed gastric emptying, and central satiety pathways. These endpoints are studied in metabolic and weight-related research models.
Primary research applications
Weight-management research
The dominant research theme is appetite and body-weight modeling via GLP-1 signaling.
Glucose-metabolism research
Studied for glucose-dependent insulin and metabolic endpoints.
Comparative GLP-1 studies
Frequently compared with Tirzepatide in dual-pathway research.
Research dosing reference
Research references describe a titration model from 0.25 mg up to 2.4 mg weekly over several weeks. Reference values only.
Reconstitution & handling
Semaglutide ships as a lyophilized (freeze-dried) powder and must be reconstituted before use in any liquid research model. Allow the vial to reach room temperature, swab the stopper, then add bacteriostatic water slowly down the inside wall of the vial - never spray it directly onto the powder. Swirl gently until dissolved; do not shake, as shaking foams the solution and stresses the peptide. The volume of water you add sets the concentration: a 5 mg vial reconstituted with 2 mL yields 2,500 mcg/mL, so 0.1 mL measures 250 mcg. A correctly reconstituted Semaglutide solution is clear; discard if it is cloudy or shows particulate.
Storage & stability
Store un-reconstituted Semaglutide vials refrigerated and protected from light for long-term stability; the lyophilized form is robust and tolerates shipping. After reconstitution, refrigerate at 2-8C, keep away from light, and use within the typical research window of roughly two to four weeks. The benzyl alcohol in bacteriostatic water helps inhibit microbial growth across that period. Always label reconstituted vials with the concentration and date.
Common research pairings
In research it is studied as a standalone GLP-1 model or compared head-to-head with Tirzepatide.
How Semaglutide compares
Semaglutide is a single-pathway GLP-1 agonist; Tirzepatide is a dual GLP-1/GIP agonist. The two are the central comparison in modern metabolic-peptide research.
Safety & research considerations
Semaglutide is supplied for research use only here and is not for human consumption; the GLP-1 literature notes gastrointestinal effects in models.
Sourcing, purity & Certificate of Analysis
Every lot of Semaglutide sold by Peptides Factory Direct is third-party tested to a 99%+ purity target, with identity confirmed by mass spectrometry and purity quantified by HPLC. A Certificate of Analysis (COA) documenting these results is available on request and ties each vial to a tracked lot. Material ships nationwide to all 50 US states with cold-chain handling where appropriate and fast domestic dispatch. This documentation is what separates research-grade Semaglutide from unverified material - quality is established before the vial ever reaches your lab.
Buy Semaglutide for research
Available research sizes:
How to order Semaglutide for research
Semaglutide can be ordered through the Peptides Factory Direct research portal as a one-time purchase or on a recurring research schedule (every 2 weeks, monthly, every 2 months, or every 3 months). Checkout requires confirming you are 21 or older, purchasing for laboratory research only, and that the product is not for human or animal consumption. Bulk and standing-order pricing is available - note it in your order. Open the order portal to view current research sizes and pricing.
Frequently asked questions
What is semaglutide studied for?
GLP-1-mediated metabolic and weight-related research endpoints, including glucose handling and satiety. Research use only - not for human consumption.
Semaglutide vs tirzepatide?
Semaglutide is a GLP-1 agonist; tirzepatide is a dual GLP-1/GIP agonist. Both are central to metabolic-peptide research.
What sizes are stocked?
2 mg, 5 mg, and 10 mg vials, third-party tested, COA on request.
Is this for human use?
No. It is supplied strictly for laboratory research use only.
Related Fat Loss & Weight Management peptides
All Fat Loss & Weight Management peptides · Research guides & articles
External references: Peptides (Wikipedia) · U.S. Food and Drug Administration